Group structure
7 companies in 4 countries
Loading your pageโฆ
Loading your pageโฆ
7 companies in 4 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 350
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACEVET 25 INJECTABLE25 mg / ml ยท Solution | Acepromazine | Canada | Marketed | 1981 |
| ANTI GAZ EMULSION FLAVOURED2 mg / ml ยท Emulsion | Docusate | Canada | Marketed | 1965 |
| AURIZON10 mg / ml + 0.9 mg / ml + 3 mg / ml ยท Suspension | Clotrimazole, Dexamethasone, Marbofloxacin | Canada | Marketed | 2010 |
| BIOESTROVET250 mcg / ml ยท Solution | Cloprostenol | Canada | Marketed | 2017 |
| BIOESTROVET SWINE87.5 mcg / ml ยท Solution | Cloprostenol | Canada | Marketed | 2024 |
| BUTEQUINE1 g / 3 ml ยท Paste | Phenylbutazone | Canada | Not marketed | 1982 |
| CALF-LYTE II0.012 g / 76 g + 41.734 g / 76 g + 6.756 g / 76 g + 1.940 g / 76 g + 0.349 g / 76 g + 13.125 g / 76 g + 3.507 g / 76 g + 0.600 g / 76 g ยท Powder For Solution | D-pantothenic acid, Dextrose, Glycine, Potassium chloride, Dibasic, Sodium acetate, Sodium chloride, Monobasic | Canada | Marketed | 2000 |
| CALF-LYTE II HE0.012 g / 185 g + 149.04 g / 185 g + 6.756 g / 185 g + 1.940 g / 185 g + 0.349 g / 185 g + 13.127 g / 185 g + 3.507 g / 185 g + 0.600 g / 185 g ยท Powder For Solution | D-pantothenic acid, Dextrose, Glycine, Potassium chloride, Dibasic, Sodium acetate, Sodium chloride | Canada | Marketed | 2000 |
| CEFASEPTIN 300 MG300 mg ยท Tablet (Chewable) | Cefalexin | Canada | Marketed | 2017 |
| CEFASEPTIN 75 MG75 mg ยท Tablet (Chewable) | Cefalexin | Canada | Authorised | |
| CEFASEPTIN 750 MG750 mg ยท Tablet (Chewable) | Cefalexin | Canada | Marketed | 2017 |
| CHLOR PALM 250 (CHLORAMPHENICOL PALMITATE ORAL SUSPENSION)50 mg / ml ยท Suspension | Chloramphenicol | Canada | Marketed | 1988 |
| CLAVASEPTIN 250 MG200 mg + 50 mg ยท Tablet (Chewable) | Amoxicillin, Clavulanic acid | Canada | Marketed | 2008 |
| CLAVASEPTIN 50 MG40 mg + 10 mg ยท Tablet (Chewable) | Amoxicillin, Clavulanic acid | Canada | Marketed | 2008 |
| CLAVASEPTIN 500 MG400 mg + 100 mg ยท Tablet (Chewable) | Amoxicillin, Clavulanic acid | Canada | Marketed | 2008 |
| CLAVASEPTIN 62.5MG50 mg + 12.5 mg ยท Tablet (Chewable) | Amoxicillin, Clavulanic acid | Canada | Marketed | 2013 |
| CLAVASEPTIN 750 MG600 mg + 150 mg ยท Tablet (Chewable) | Amoxicillin, Clavulanic acid | Canada | Marketed | 2023 |
| COTHIVET TOPICAL SPRAY89.5 % ยท Spray | Hydrocotyle | Canada | Not marketed | 1993 |
| DEXAFER-200200 mg / ml ยท Solution | Iron | Canada | Marketed | 2005 |
| DEXAMETHASONE 2 STERILE INJECTABLE SOLUTION2 mg / ml ยท Solution | Dexamethasone | Canada | Marketed | 1985 |
| DEXAMETHASONE 5 STERILE INJECTABLE SOLUTION5 mg / ml ยท Solution | Dexamethasone | Canada | Marketed | 1983 |
| DOLPAC 10559.0 mg + 50.0 mg + 144.0 mg ยท Tablet | Oxantel, Praziquantel, Pyrantel | Canada | Marketed | 2010 |
| DOLPAC 2111.8 mg + 10.0 mg + 28.8 mg ยท Tablet | Oxantel, Praziquantel, Pyrantel | Canada | Marketed | 2010 |
| DOLPAC 251397.5 mg + 125.0 mg + 360.0 mg ยท Tablet | Oxantel, Praziquantel, Pyrantel | Canada | Marketed | 2010 |
| EPIPHEN 30MG30 mg ยท Tablet | Phenobarbital | Canada | Marketed | 2014 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 350 | 47 | 303 | CompaniesAll medicines |
Also in the registers of Italy
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Czech Ministry of Finance, ARES; Ministry of Justice commercial register (VR), Czech Statistical Office (RES), exact IฤO, source record datumAktualizace and retrieval date. Structured extraction by Prognia.
Licence: Czech statutory open data; ARES reuse and operating terms
INSEE (www.insee.fr), via DINUM API Recherche dโentreprises; include original record update date and retrieval date
Licence: Licence Ouverte / Open Licence
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: ยฉ OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence: Italian Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.